Perioperative fluid management in major hepatic resection: an integrative review
Osamu Yoshino, Marcos Vinicius Perini, Christopher Christophi and Laurence Weinberg
Melbourne, Australia
Author Affiliations: Department of Surgery, Austin Hospital and University of Melbourne, Melbourne, Victoria, Australia (Yoshino O, Perini MV, Christophi C and Weinberg L); Anaesthesia Perioperative Pain Medicine Unit, University of Melbourne, Melbourne, Victoria, Australia (Weinberg L)
Corresponding Author: Osamu Yoshino, MD, PhD, Department of Surgery, Austin Hospital, Austin Health, 145 Studley Rd, Heidelberg VIC 3084, Australia (Tel: +61-3-9496-5000; Fax: +61-3-9458-1650: Email: osamu.yoshino@austin.org.au, Osamu1979@mac.com)
Abstract：BACKGROUND: Fluid intervention and vasoactive pharmacological support during hepatic resection depend on the preference of the attending clinician, institutional resources, and practice culture. Evidence-based recommendations to guide perioperative fluid management are currently limited. Therefore, we provide a contemporary clinical integrative overview of the fundamental principles underpinning fluid intervention and hemodynamic optimization for adult patients undergoing major hepatic resection.
DATA SOURCES: A literature review was performed of MEDLINE, EMBASE and the Cochrane Central Registry of Controlled Trials using the terms “surgery”, "anesthesia”, "starch”, "hydroxyethyl starch derivatives”, "albumin”, "gelatin”, "liver resection”, "hepatic resection”, "fluids”, "fluid therapy”, "crystalloid”, "colloid”, "saline”, "plasma-Lyte”, "plasmalyte”, "hartmann’s”, "acetate”, and “lactate”. Search results for MEDLINE and EMBASE were additionally limited to studies on human populations that included adult age groups and publications in English.
RESULTS: A total of 113 articles were included after appropriate inclusion criteria screening. Perioperative fluid management as it relates to various anesthetic and surgical techniques is discussed.
CONCLUSIONS: Clinicians should have a fundamental understanding of the surgical phases of the resection, hemodynamic goals, and anesthesia challenges in attempts to individualize therapy to the patient’s underlying pathophysiological condition. Therefore, an ideal approach for perioperative fluid therapy is always individualized. Planning and designing large-scale clinical trials are imperative to define the optimal type and amount of fluid for patients undergoing major hepatic resection. Further clinical trials evaluating different intraoperative goal-directed strategies are also eagerly awaited.
2017, Vol. 16 
